In this prospective observational study, we explored the correlation between plasma EBV-DNA levels and clinical features (such as response rate and survival) in early-stage NKTCL patients treated with upfront asparaginase-based chemotherapy (GELOX or CHOPL) followed by radiotherapy. This evidence concerns the gene ASPG and extranodal nasal NK/T cell lymphoma.